p73 is over-expressed in vulval cancer principally as the Δ2 isoform

被引:43
|
作者
O'Nions, J
Brooks, LA
Sullivan, A
Bell, A
Dunne, B
Rozycka, M
Reddy, A
Tidy, JA
Evans, D
Farrell, PJ
Evans, A
Gasco, M
Gusterson, B
Crook, T
机构
[1] St Marys Hosp, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England
[2] Univ Glasgow, Western Infirm, Dept Pathol, Glasgow G11 6NT, Lanark, Scotland
[3] Univ London Kings Coll, Sch Med & Dent, Dept Mol Med, London SE5, England
[4] Univ Sheffield, No Gen Hosp, Dept Gynaecol Oncol, Sheffield S5 7AU, S Yorkshire, England
[5] St Marys Hosp, Sch Med, Dept Histopathol, London W2, England
[6] Poole Hosp NHS Trust, Dept Surg, Poole, Dorset, England
[7] Azienda Osped S Croce & Carle, UO Oncol Med, I-12100 Cuneo, Italy
关键词
vulval cancer; HPV; p73;
D O I
10.1054/bjoc.2001.2138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p73 was studied in squamous cancers and precursor lesions of the vulva. Over-expression of p73 occurred commonly in both human papillomavirus (HPV)-positive and -negative squamous cell cancers (SCC) and high-grade premalignant lesions. Whereas expression in normal vulval epithelium was detected only in the basal and supra-basal layers, expression in neoplastic epithelium increased with grade of neoplasia, being maximal at both protein and RNA levels in SCC. p73 Delta2 was the principal over-expressed isoform in the majority of cases of vulval SCC and often the sole form expressed in SCC. Over-expression of p73 was associated with expression of HPV-encoded E7 or with hypermethylation or mutation of p16(INK4a) in HPV-negative cases. There was a close correlation between expression of p73 and p14(ARF) in cancers with loss of p53 function. The frequent over-expression of p73 Delta2 in neoplastic but not normal vulval epithelium, and its co-ordinate deregulation with other E2F-1 responsive genes suggests a role in the oncogenic process. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1551 / 1556
页数:6
相关论文
共 50 条
  • [31] 5′-inositol phosphatase 2 (SHIP2) is over-expressed in endometrial cancer
    Sever, M
    Tandon, M
    Prasad, N
    Badve, S
    MODERN PATHOLOGY, 2006, 19 : 195A - 195A
  • [32] MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function
    Wu, Hong
    Leng, Roger P.
    ONCOTARGET, 2015, 6 (25) : 21479 - 21492
  • [33] 5′-inositol phosphatase 2 (SHIP2) is over-expressed in endometrial cancer
    Sever, M
    Tandon, M
    Prasad, N
    Badve, S
    LABORATORY INVESTIGATION, 2006, 86 : 195A - 195A
  • [34] Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond
    Logotheti, Stella
    Richter, Christin
    Murr, Nico
    Spitschak, Alf
    Marquardt, Stephan
    Puetzer, Brigitte M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [35] Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
    Fillippovich, I
    Sorokina, N
    Gatei, M
    Haupt, Y
    Hobson, K
    Moallem, E
    Spring, K
    Mould, M
    McGuckin, MA
    Lavin, MF
    Khanna, KK
    ONCOGENE, 2001, 20 (04) : 514 - 522
  • [36] Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
    Igor Fillippovich
    Natasha Sorokina
    Magtouf Gatei
    Ygal Haupt
    Karen Hobson
    Eli Moallem
    Kevin Spring
    Michelle Mould
    Michael A McGuckin
    Martin F Lavin
    Kum Kum Khanna
    Oncogene, 2001, 20 : 514 - 522
  • [37] Activation of p73 silent allele in lung cancer
    Mai, M
    Yokomizo, A
    Qian, CP
    Yang, P
    Tindall, DJ
    Smith, DI
    Liu, WG
    CANCER RESEARCH, 1998, 58 (11) : 2347 - 2349
  • [38] Engineering Clonal Human Cell Lines Stably Expressing a Single p73 Isoform
    Cordova, Ricardo A.
    Gushterova, Irena
    Carastro, L. Michael
    FASEB JOURNAL, 2016, 30
  • [39] p73 expression in human normal and tumor tissues:: Loss of p73α expression is associated with tumor progression in bladder cancer
    Puig, P
    Capodieci, P
    Drobnjak, M
    Verbel, D
    Prives, C
    Cordon-Cardo, C
    Di Como, CJ
    CLINICAL CANCER RESEARCH, 2003, 9 (15) : 5642 - 5651
  • [40] IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells
    Cui, Lei
    Deng, Yuezhen
    Rong, Yefei
    Lou, Wenhui
    Mao, Zhengfa
    Feng, Yuanyuan
    Xie, Dong
    Jin, Dayong
    TUMOR BIOLOGY, 2012, 33 (01) : 247 - 255